Ibuprofen heterocyclic esters as dermal prodrugs in vitro evaluation

S.T.P. Pharma Sciences

Volumn 7, Issue 4, 1997, Pages 315-319

  Chang, S Y ^a   Park, S B ^b   Jung, J H ^b   Shon, S I ^b   Yoon, H J ^b  

^a Central Research Institute   (South Korea)

^b NONE

Author keywords

Ester prodrug; Ibuprofen; Skin permeation enzymatic hydrolysis

Indexed keywords

IBUPROFEN;

ARTICLE; DRUG DEGRADATION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG PENETRATION; DRUG STABILITY; INFLAMMATION;

EID: 0031543964     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. ADAMS S.S., McCULLOUGH K.F. and NICHOLSON J.SThe pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic agents, Arch. Int. Pharmacodyn. 178, 115-129, 1969.
2. COLLUM L.M.T. and BOWEN D.I Ocular side-effects of ibuprofen - Br. J. Ophthalmol., 55, 472-477, 1971.
3. HADGRAFT J Prodrugs and skin absorption In : Design of Prodrugs, H. Bundgaard Ed., Eisevier, Amsterdam, 1985, pp. 274-275.
4. YANO T., NAKAGAWA A., TSUJI M. and NODA K Skin permeability of various non-steroidal anti-inflammatory drugs in man Life Sei, 39, 1043-1050, 1986.
5. IRWIN W.J., SANDERSON F.D. and LI WAN PO A. Percutaneous absorption of ibuprofen and naproxen : effect of amide enhancers on transport through rat skin Int. J. Pharm., 66,243-252, 1990.
6. BARRY B.W Dermatological Formulations Marcel Dekker Inc., New York, 1983, pp. 49-94.
7. MUELLER L.G Novel anti-inflammatory esters, pharmaceutical compositions and methods for reducing inflammation UK Patent GB 2 204 869A, 23 November 1988.
8. MOORE D.R. and MATHIAS L.J Mesoionic polymerization. Poly(oxyvinylene)lactams from N-(chloroacetyl)lactams through an isomunchone intermediate Macromolecules, 19, 15301536, 1986.
9. BONINA P.P., MONTENEGRO L, TRAPANI G, FRANCO M. and LISO G In vitro evaluation of N-acyllactam esters of indomethacin as dermal prodrugs Int. J. Pharm., 124, 45-51, 1995.
10. WONG O., TSUZUKI N., NEGHIEM B., KUEHNHOFF J., ITOH T., MASAKI K., HUNTINGTON J., KONISHI R., RYTTING J.H. and HIGUCHI T Unsaturated cyclic ureas as new non-toxic biodegradable transdermal penetration enhancers. II : Evaluation study Int. J. Pharm., 52, 191-202, 1989.
11. BARRY B.W Dermatological Formulations Marcel Dekker Inc., New York, 1983, pp. 160-172.
12. BUNDGAARD H Design of prodrugs Elsevier, Amsterdam, 1985, p. 272.
13. BONINA F.P., MONTENEGRO, DE CAPRARIS P., BOUSQUET E. and TIRENDI S l-Alkylazacyclo-alkan-2-one esters as prodrugs of indomethacin for improved delivery through human skin Int. J. Pharm., 77, 21-29, 1991.